PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12594260-3	2003	Treatment by BP markedly inhibited the formation of adherent macrophagic cells deriving from monocytes upon the action of either GM-CSF or M-CSF.	Benzo(a)pyrene	13-15	colony stimulating factor 2	Homo sapiens	129-135	
11884429-3	2002	Exposure to BP during monocyte differentiation into DC upon the action of GM-CSF and IL-4 markedly inhibited the up-regulation of markers found in DC such as CD1a, CD80, and CD40, without altering cell viability.	Benzo(a)pyrene	12-14	colony stimulating factor 2	Homo sapiens	74-80	
2473889-6	1989	We conclude that the BRL 3A BP (rBP-30) is the major insulin-like growth factor binding protein in the rat CNS and may be the rat analog of hBP-31, the predominant BP in human CSF.	Benzo(a)pyrene	28-30	colony stimulating factor 2	Homo sapiens	176-179	
6201907-7	1984	Consideration of the temporal and immunochemical relationships as well as of the differential diagnosis provides a basis for the understanding of the significance of BP, its antibodies and other immunoglobulins in the CSF.	Benzo(a)pyrene	166-168	colony stimulating factor 2	Homo sapiens	218-221	
6085224-5	1984	The amount of BP-like material that enters CSF and cross-reacts with BP peptide 43-88 is related to the recognition of an epitope or epitopes in the C-terminal portion of this peptide.	Benzo(a)pyrene	14-16	colony stimulating factor 2	Homo sapiens	43-46	
6085224-5	1984	The amount of BP-like material that enters CSF and cross-reacts with BP peptide 43-88 is related to the recognition of an epitope or epitopes in the C-terminal portion of this peptide.	Benzo(a)pyrene	69-71	colony stimulating factor 2	Homo sapiens	43-46